Key facts

Invented name
  • Rienso
  • Rienso
Active Substance
Ferumoxytol
Therapeutic area
  • Haematology-Hemostaseology
  • Uro-nephrology
Decision number
P/0109/2022
PIP number
EMEA-000373-PIP02-09-M05
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of iron deficiency anaemia (IDA)
Route(s) of administration
Intravenous use
Contact for public enquiries

Covis Pharma Europe B.V.

Email: medinfoEMEA@covispharma.com
Tel. 08000270008

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page